Page last updated: 2024-08-23

dermatan sulfate and Disease Models, Animal

dermatan sulfate has been researched along with Disease Models, Animal in 54 studies

Research

Studies (54)

TimeframeStudies, this research(%)All Research%
pre-19908 (14.81)18.7374
1990's11 (20.37)18.2507
2000's13 (24.07)29.6817
2010's17 (31.48)24.3611
2020's5 (9.26)2.80

Authors

AuthorsStudies
Capitani, F; D'Avanzo, F; Gabrielli, O; Galeotti, F; Maccari, F; Mantovani, V; Rigon, L; Salvalaio, M; Tomanin, R; Volpi, N; Zanetti, A1
Bocart, S; Bouchot, A; Bournique, B; Broqua, P; Entchev, E; Jantzen, I; Junien, JL; Lacombe, O; Luccarini, JM; Masson, P; Tallandier, M1
Arguello, A; Astarita, G; Bhalla, A; Costanzo, S; Davis, SS; Dugas, JC; Fang, M; Gunasekaran, K; Guo, JL; Harris, JM; Henne, KR; Henry, AG; Poda, SB; Ravi, R; Skuja, LL; Sweeney, ZK; Thomsen, E; Tsogtbaatar, B; Ullman, JC; Wang, J1
Daniel, RA; Desilva, K; Du, QS; Masci, PP; Osborne, SA; Seymour, RB; Vitetta, L; Zhao, KN1
Coulson-Thomas, VJ; Elliott, G; Gesteira, TF; Hughes, C; Moreno, IY; Mutoji, KN; Sun, M1
Dörr, W; Frings, K; Gruber, S; Kuess, P1
Amling, M; Busse, B; Chan, D; Chan, WL; Egerer, J; Hausser, I; Khayal, LA; Knaus, P; Kolanczyk, M; Kornak, U; Lowe, M; Mizumoto, S; Mundlos, S; Ott, CE; Paganini, C; Pestka, JM; Rossi, A; Schinke, T; Steiner, M; Sugahara, K; Willie, B; Witkos, T; Zhang, H1
Arnold, M; Cini, N; Dörr, W; Gernedl, V; Gruber, S; Hetzendorfer, S; Kowald, LM; Kuess, P; Mayer, J; Morava, S; Pfaffinger, S; Rohorzka, A1
Kida, S; Kinoshita, M; Morimoto, H; Shibasaki, T; Tachibana, K; Tanaka, N; Yamamoto, R1
Gao, W; Li, W; Xu, J; Xu, S; Yu, Z1
Kawano, H; Kimura-Kuroda, J; Komuta, Y; Li, HP; van Kuppevelt, TH1
Baracat, EC; Gomes, RC; Maioral, GC; Nader, HB; Patriarca, MT; Simões, RS; Soares, JM; Verna, C1
Bravo, AI; Calabrese, GC; Gazzaniga, S; Maccari, F; Oberkersch, R; Volpi, N1
Eklund, E; Grottling, E; Gustafsson, R; Maccarana, M; Malmström, A; Oldberg, A; Stachtea, X1
Akyüz, N; Huckhagel, T; Jakovcevski, I; Martinovic, T; Rost, S; Schachner, M1
Bavington, CD; Hogwood, J; Moss, C; Mulloy, B; Page, CP; Panagos, CG; Robinson, J; Spina, D; Thomson, D; Uhrín, D; Venkatasamy, R1
Akiyama, K; Higuchi, T; Ida, H; Kobayashi, H; Nakauchi, H; Ohashi, T; Ohteki, T; Otsu, M; Sato, T; Shimada, Y; Yokoi, K; Yokoi, T1
Arasaradnam, M; Bigger, BW; Langford-Smith, K; Wraith, JE; Wynn, R1
Hagiwara, S; Iwasaka, H; Matsumoto, S; Mizunaga, S; Nishida, T; Noguchi, T; Saikawa, T; Shingu, C; Uchida, T1
Kolb, M; Ludwig, MS; Netter, P; Ouzzine, M; Venkatesan, N1
Belmiro, CL; Gonçalves, RG; Kozlowski, EO; Leite, M; Pavão, MS; Takyia, CM; Werneck, AF1
Lagarde, N; Marcorelles, P; Uguen, A; Zanchetta, P1
Roehrl, MH; Wang, JY1
He, L; Pavão, MS; Tollefsen, DM; Vicente, CP1
Cardin, AD; Hong, TT; Lucchesi, BR; Van Gorp, CL1
Gonçalves, RG; Leite, M; Martinusso, CA; Pavão, MS; Pecly, IM; Rangel, EP; Taboada, FS; Takiya, CM1
Braga, LM; Burin, M; Camassola, M; Dalberto, TP; Delgado-Cañedo, A; Giugliani, R; Matte, U; Nardi, NB1
Tollefsen, DM1
Baker, JR; Moring, AG; Norton, TT1
Fahey, M; Gohr, CM; Rosenthal, AK1
Hobbelen, PM; Meuleman, DG; Moelker, HC; van Dedem, G1
Blackwood, RA; Cantor, JO; Mandl, I; Moret, J; Turino, GM1
Deppmeier, L; Farrell, S; Grossmann, E; Johnson, E; Moore, CG; Morrison, J1
Cesmeli, S; Davies, AB; Gray, E; Lane, DA; Lormeau, JC1
Bellenger, CR; Ghosh, P; Little, CB1
Koide, N; Sasaki, S; Shinji, T; Tsuji, T1
Buczko, W; D'Adamo, MC; Donati, MB; Iacoviello, L; Pawlak, K; Polishchuck, R; Wollny, T1
Crawley, AC; Hopwood, JJ; Muller, VJ; Yogalingam, G1
Ghosh, P; Latham, J; Melrose, J; Moore, R; Taylor, TK; Vernon-Roberts, B1
Horie, K; Kyogashima, M; Miyauchi, S; Mizuno, S; Onaya, J; Sunose, A1
Arai, M; Kyogashima, M; Miyauchi, S; Onaya, J; Sakai, T; Shibata, Y; Suda, A; Takada, A; Takada, Y1
Mourão, PA; Pacheco, RG; Vicente, CP; Zancan, P1
Conard, J; Elalamy, I; Horellou, MH; Lecrubier, C; Samama, MM1
Fujishima, Y; Miyake, Y; Sukamoto, T; Yokota, K1
Alves-Sá, R; Araújo, FS; Mourão, PA; Pavão, MS; Peixoto, LL; Vicente, CP; Zancan, P1
Cardin, AD; Driscoll, EM; Hennan, JK; Hong, TT; Lucchesi, BR; Shergill, AK1
Kischer, CW; Shetlar, CL; Shetlar, MR1
Alvarez, R; Fussi, F; Santoro, FM1
Ammitzbøll, T; Brok, KE; Jørgensen, B; Olsen, EB; Trier, K1
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM1
Barrowcliffe, TW; Merton, RE; Thomas, DP1
Oparil, S; Reynertson, RH; Rodén, L1
Boneu, B; Caranobe, C; Choay, J; Dol, F; Dupouy, D; Lormeau, JC; Petitou, M; Sié, P1
Constantopoulos, G; Hastings, N; Neufeld, EF; Shull, RM1

Reviews

2 review(s) available for dermatan sulfate and Disease Models, Animal

ArticleYear
Heparin cofactor II modulates the response to vascular injury.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:3

    Topics: Animals; Atherosclerosis; Coronary Restenosis; Dermatan Sulfate; Disease Models, Animal; Female; Heparin Cofactor II; Humans; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Pregnancy; Sensitivity and Specificity; Structure-Activity Relationship; Thrombin; Thrombosis; Tunica Intima

2007
Heparin-induced thrombocytopenia: laboratory diagnosis and management.
    Annals of medicine, 2000, Volume: 32 Suppl 1

    Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Immunoassay; Platelet Activation; Recombinant Proteins; Thrombocytopenia

2000

Other Studies

52 other study(ies) available for dermatan sulfate and Disease Models, Animal

ArticleYear
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.
    Journal of molecular medicine (Berlin, Germany), 2022, Volume: 100, Issue:8

    Topics: Animals; Biomarkers; Body Fluids; Dermatan Sulfate; Disaccharides; Disease Models, Animal; Enzyme Replacement Therapy; Glycosaminoglycans; Heparitin Sulfate; Mice; Mice, Knockout; Mucopolysaccharidosis II

2022
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Administration, Oral; Animals; Cattle; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Endothelial Cells; Female; Glycosaminoglycans; Glycosides; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mucopolysaccharidosis VI; Rats; Rats, Sprague-Dawley

2020
High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.
    International journal of molecular sciences, 2020, Jul-30, Volume: 21, Issue:15

    Topics: Animals; Biomarkers; Blood-Brain Barrier; Brain; Chromatography, Liquid; Dermatan Sulfate; Disaccharides; Disease Models, Animal; Glycosaminoglycans; Heparitin Sulfate; Humans; Iduronate Sulfatase; Mice; Mucopolysaccharidosis II; Tandem Mass Spectrometry

2020
Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.
    Inflammopharmacology, 2021, Volume: 29, Issue:2

    Topics: Administration, Oral; Animals; Anticoagulants; Cattle; Collagen; Dermatan Sulfate; Disease Models, Animal; Enoxaparin; Male; Rabbits; Thrombelastography; Venous Thromboembolism; Venous Thrombosis

2021
Extracellular Matrix Deposition and Remodeling after Corneal Alkali Burn in Mice.
    International journal of molecular sciences, 2021, May-27, Volume: 22, Issue:11

    Topics: Alkalies; Animals; Biomarkers; Burns, Chemical; Corneal Diseases; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Eye Burns; Fluorescent Antibody Technique; Gene Expression; Glycosaminoglycans; Heparitin Sulfate; Keratan Sulfate; Mice; Proteoglycans

2021
Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2018, Volume: 194, Issue:7

    Topics: Animals; Dermatan Sulfate; Disease Models, Animal; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Injections, Subcutaneous; Male; Mice; Mice, Inbred C3H; Otorhinolaryngologic Neoplasms; Radiation Injuries; Stomatitis; Tongue

2018
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica.
    PLoS genetics, 2018, Volume: 14, Issue:3

    Topics: Animals; Bone Diseases; Cell Differentiation; Decorin; Dermatan Sulfate; Disease Models, Animal; Dwarfism; Female; Fractures, Bone; Glycosylation; Golgi Matrix Proteins; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mice, Transgenic; Osteoblasts; Proteoglycans; Signal Transduction; Skin Diseases, Genetic; Transforming Growth Factor beta; Vesicular Transport Proteins

2018
Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation.
    International journal of molecular sciences, 2018, 06-06, Volume: 19, Issue:6

    Topics: Animals; Cell Proliferation; Dermatan Sulfate; Disease Models, Animal; Head and Neck Neoplasms; Hypoxia; Inflammation; Intercellular Junctions; Mice; Radiation-Protective Agents; Radiotherapy; Stomatitis

2018
Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Molecular genetics and metabolism, 2018, Volume: 125, Issue:1-2

    Topics: Animals; Biomarkers; Blood-Brain Barrier; Brain; Chromatography, Liquid; Dermatan Sulfate; Disease Models, Animal; Heparitin Sulfate; Humans; Iduronate Sulfatase; Mice; Mice, Knockout; Mucopolysaccharidosis II; Nervous System Diseases; Receptors, Transferrin; Tandem Mass Spectrometry

2018
Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis.
    The Journal of international medical research, 2019, Volume: 47, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Anticoagulants; Bleomycin; Dermatan Sulfate; Disease Models, Animal; Female; Hydroxyproline; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis

2019
Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain.
    Journal of neurotrauma, 2013, Mar-01, Volume: 30, Issue:5

    Topics: Animals; Astrocytes; Axons; Brain Injuries; Chondroitin Sulfates; Cicatrix; Coculture Techniques; Dermatan Sulfate; Disease Models, Animal; Fibroblasts; Fluorescent Antibody Technique; Immunohistochemistry; Male; Mice; Mice, Inbred ICR; Nerve Regeneration; Rats; Rats, Sprague-Dawley

2013
Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle.
    Fertility and sterility, 2013, Volume: 100, Issue:5

    Topics: Animals; Biomarkers; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Estradiol; Estrous Cycle; Female; Glycosaminoglycans; Heparitin Sulfate; Hyperprolactinemia; Metoclopramide; Mice; Progesterone; Time Factors; Uterus

2013
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model.
    International journal of experimental pathology, 2014, Volume: 95, Issue:3

    Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Chondroitin Sulfate Proteoglycans; Dermatan Sulfate; Diet, Atherogenic; Disease Models, Animal; Extracellular Matrix; Gene Expression Regulation; Glycosaminoglycans; Goats; Humans; Hypercholesterolemia; Lipids; Male; Plaque, Atherosclerotic; Rabbits; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2014
Dermatan sulfate epimerase 1 deficient mice as a model for human abdominal wall defects.
    Birth defects research. Part A, Clinical and molecular teratology, 2014, Volume: 100, Issue:9

    Topics: Abdominal Wall; Animals; Carbohydrate Epimerases; Dermatan Sulfate; Dermis; Disease Models, Animal; Embryo, Mammalian; Gene Expression; Hernia, Abdominal; Humans; Keratin-1; Keratin-15; Keratinocytes; Mice; Mice, Knockout; Neural Tube Defects; Spinal Dysraphism

2014
Germline ablation of dermatan-4O-sulfotransferase1 reduces regeneration after mouse spinal cord injury.
    Neuroscience, 2016, Jan-15, Volume: 312

    Topics: Animals; Behavior, Animal; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Mice; Motor Activity; Nerve Regeneration; Recovery of Function; Spinal Cord Injuries; Sulfotransferases

2016
Structural characterization and anti-inflammatory activity of two novel polysaccharides from the sea squirt, Ascidiella aspersa.
    Pulmonary pharmacology & therapeutics, 2016, Volume: 40

    Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Dermatan Sulfate; Disease Models, Animal; Glycosaminoglycans; Humans; Inflammation; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Molecular Weight; Polysaccharides; Urochordata

2016
Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II.
    Molecular genetics and metabolism, 2016, Volume: 119, Issue:3

    Topics: Animals; Antibodies, Anti-Idiotypic; Bone Marrow Transplantation; Dermatan Sulfate; Disease Models, Animal; Glycoproteins; Heparitin Sulfate; Humans; Lysosomes; Mice; Mice, Knockout; Mucopolysaccharidosis II; Proto-Oncogene Proteins c-kit

2016
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Molecular genetics and metabolism, 2010, Volume: 99, Issue:3

    Topics: Animals; Biomarkers; Blood Specimen Collection; Dermatan Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heparin Cofactor II; Heparitin Sulfate; Humans; Mice; Mice, Inbred C57BL; Mucopolysaccharidosis I; Mucopolysaccharidosis III; Thrombin

2010
Danaparoid sodium attenuates the effects of heat stress.
    The Journal of surgical research, 2011, Volume: 171, Issue:2

    Topics: Acute Disease; Animals; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Cytokines; Dermatan Sulfate; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Heat Exhaustion; Heat Stroke; Heparitin Sulfate; HMGB1 Protein; Inflammation; Intestine, Small; Liver; Lung; Male; Nitrates; Nitric Oxide; Nitrites; Peptide Hydrolases; Rats; Rats, Wistar; Survival Rate

2011
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.
    American journal of physiology. Lung cellular and molecular physiology, 2011, Volume: 300, Issue:2

    Topics: Animals; Bleomycin; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Fibroblasts; Glucuronosyltransferase; Humans; Hyaluronic Acid; Idiopathic Pulmonary Fibrosis; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Distribution; Transforming Growth Factor beta1; Up-Regulation

2011
Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2011, Volume: 44, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Chemokine CCL2; Dermatan Sulfate; Disease Models, Animal; Fibrosis; Injections, Subcutaneous; Kidney; Macrophage Activation; Macrophages; Male; Mice; Myofibroblasts; Nephritis; Transforming Growth Factor beta; Ureteral Obstruction

2011
Mixture of hyaluronic acid, chondroitin 6 sulphate and dermatan sulphate used to completely regenerate bone in rat critical size defect model.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2012, Volume: 40, Issue:8

    Topics: Animals; Biocompatible Materials; Bone Diseases; Bone Regeneration; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Hyaluronic Acid; Male; Neovascularization, Physiologic; Osteogenesis; Parietal Bone; Periosteum; Rats; Rats, Wistar; Time Factors; Wound Healing

2012
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Oct-29, Volume: 99, Issue:22

    Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Bone Marrow Cells; CD4-Positive T-Lymphocytes; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Female; Glycosaminoglycans; Heparin; Humans; Hyaluronic Acid; Immunophenotyping; Mice; Mice, Inbred C57BL

2002
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
    Blood, 2004, Dec-15, Volume: 104, Issue:13

    Topics: Animals; Antithrombins; Carotid Artery Thrombosis; Dermatan Sulfate; Disease Models, Animal; Heparin Cofactor II; Humans; Mice; Mice, Knockout; Recombination, Genetic; Skin; Swine

2004
Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
    Thrombosis research, 2006, Volume: 117, Issue:3

    Topics: Animals; Anticoagulants; Arteries; Bleeding Time; Blood Coagulation; Blood Platelets; Dermatan Sulfate; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heparin Cofactor II; Male; Models, Chemical; Platelet Aggregation; Prothrombin Time; Recombinant Proteins; Thrombin; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator

2006
Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:5

    Topics: Animals; Biomarkers; Biopsy, Needle; Cell Movement; Chondroitin; Chondroitin Sulfate Proteoglycans; Collagen; Dermatan Sulfate; Disease Models, Animal; Down-Regulation; Fibronectins; Heparin, Low-Molecular-Weight; Immunohistochemistry; Kidney; Macrophages; Male; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Transforming Growth Factor beta; Up-Regulation; Ureteral Obstruction

2006
Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:6

    Topics: Animals; Bone Marrow Transplantation; Dermatan Sulfate; Disease Models, Animal; DNA, Complementary; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glycosaminoglycans; Heparitin Sulfate; Humans; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucopolysaccharidosis I; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Transduction, Genetic; Transfection

2005
Modulation of glycosaminoglycan levels in tree shrew sclera during lens-induced myopia development and recovery.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:7

    Topics: Animals; Chondroitin; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Electrophoresis, Capillary; Female; Hyaluronic Acid; Male; Myopia; Organ Size; Sclera; Sensory Deprivation; Tupaiidae

2007
Calcific tendonitis : a model.
    Connective tissue research, 2007, Volume: 48, Issue:6

    Topics: Animals; Calcinosis; Cartilage, Articular; Collagen Type I; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Glycerophosphates; Levamisole; Microscopy, Electron; Patellar Ligament; Sus scrofa; Tendinopathy

2007
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
    Thrombosis research, 1982, Aug-01, Volume: 27, Issue:3

    Topics: Animals; Blood Coagulation; Blood Platelets; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Male; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Thrombophlebitis

1982
Glycosaminoglycan synthesis in endotoxin-induced lung injury.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1983, Volume: 174, Issue:3

    Topics: Animals; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Endotoxins; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Lung; Pulmonary Emphysema; Rats; Rats, Inbred Strains; Time Factors

1983
Structure and composition of the rodent lamina cribrosa.
    Experimental eye research, 1995, Volume: 60, Issue:2

    Topics: Animals; Chondroitin Sulfates; Collagen; Dermatan Sulfate; Disease Models, Animal; Glaucoma; Guinea Pigs; Immunoenzyme Techniques; Optic Disk; Rats; Rats, Inbred BN

1995
Low affinity heparin is an antithrombotic agent.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:2

    Topics: Animals; Bleeding Time; Dermatan Sulfate; Disease Models, Animal; Hemorrhage; Heparin; Humans; Metabolic Clearance Rate; Rabbits; Thrombin; Thrombophlebitis

1994
Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 1996, Volume: 14, Issue:3

    Topics: Aggrecans; Animals; Biglycan; Cartilage, Articular; Chondroitin Sulfate Proteoglycans; Culture Media; Decorin; Dermatan Sulfate; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Lectins, C-Type; Male; Menisci, Tibial; Osteoarthritis; Proteoglycans; Sheep

1996
Immunohistochemical study of proteoglycans in D-galactosamine-induced acute liver injury in rats.
    Journal of gastroenterology, 1996, Volume: 31, Issue:1

    Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Galactosamine; Heparitin Sulfate; Immunohistochemistry; Liver; Liver Diseases; Male; Microscopy, Electron; Proliferating Cell Nuclear Antigen; Proteoglycans; Rats; Rats, Sprague-Dawley

1996
Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Thrombosis and haemostasis, 1996, Volume: 76, Issue:6

    Topics: Animals; Anticoagulants; Dermatan Sulfate; Disease Models, Animal; Drug Therapy, Combination; Glycosaminoglycans; Heparin; Male; Rats; Thrombosis

1996
Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
    The Journal of clinical investigation, 1998, Jan-01, Volume: 101, Issue:1

    Topics: Animals; Arthrography; beta-N-Acetylhexosaminidases; Cats; Chondro-4-Sulfatase; Dermatan Sulfate; Disease Models, Animal; Female; Genotype; Humans; Joints; Leukocytes; Male; Mucopolysaccharidosis VI; Mutation; Pedigree; Phenotype

1998
Elevated synthesis of biglycan and decorin in an ovine annular lesion model of experimental disc degeneration.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 1997, Volume: 6, Issue:6

    Topics: Animals; Autoradiography; Biglycan; Blotting, Western; Cell Division; Cells, Cultured; Chromatography, Gel; Decorin; Dermatan Sulfate; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Intervertebral Disc; Proteoglycans; Sheep; Spinal Osteophytosis

1997
Effects of dermatan sulfate, a heparin cofactor II mediated thrombin inhibitor, on the endotoxin-induced disseminated intravascular coagulation model in the rat: comparison with low-molecular weight heparin, nafamostat mesilate and argathroban.
    Japanese journal of pharmacology, 1998, Volume: 76, Issue:4

    Topics: Animals; Arginine; Benzamidines; Dermatan Sulfate; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Guanidines; Heparin; Heparin Cofactor II; Male; Molecular Weight; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides

1998
Antithrombotic activity of avian crown dermatan sulfate.
    Thrombosis research, 1999, Dec-15, Volume: 96, Issue:6

    Topics: Animals; Anticoagulants; Cattle; Chickens; Chondroitin ABC Lyase; Chromatography, Gel; Dermatan Sulfate; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Activation; Half-Life; Heparin Cofactor II; Male; Molecular Weight; Plasminogen; Rats; Species Specificity; Sulfatases; Thrombin; Tissue Plasminogen Activator; Venous Thrombosis

1999
Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2000, Volume: 11, Issue:6

    Topics: Animals; Anticoagulants; Carbohydrate Sequence; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Echinodermata; Female; Fibrinolytic Agents; Fucose; Glycosaminoglycans; Heparin; Male; Molecular Sequence Data; Molecular Weight; Partial Thromboplastin Time; Rats; Sulfur Radioisotopes; Thrombosis

2000
The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2001, Volume: 12, Issue:5

    Topics: Animals; Anticoagulants; Antithrombin III; Bleeding Time; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Models, Animal; Disseminated Intravascular Coagulation; Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Factor Xa; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Kinetics; Male; Platelet Aggregation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin

2001
Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:5

    Topics: Animals; Anticoagulants; Blood Coagulation; Cattle; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hemorrhage; Heparin Cofactor II; Male; Protein Binding; Rats; Rats, Wistar; Species Specificity; Thrombin; Thrombosis; Urochordata

2001
Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:3

    Topics: Animals; Antithrombins; Bleeding Time; Carotid Arteries; Carotid Artery Thrombosis; Constriction, Pathologic; Dermatan Sulfate; Disease Models, Animal; Dogs; Injections, Intravenous; Jugular Veins; Platelet Aggregation; Venous Thrombosis

2002
Healing of myocardial infarction in animal models.
    Texas reports on biology and medicine, 1979, Volume: 39

    Topics: Animals; Chondroitin Sulfates; Coronary Vessels; Dermatan Sulfate; Disease Models, Animal; Dogs; Glycosaminoglycans; Heart; Humans; Hyaluronic Acid; Middle Aged; Myocardial Infarction; Rats; Wound Healing

1979
Pharmacological profile of a native dermatan sulfate.
    Thrombosis research, 1992, Jul-15, Volume: 67, Issue:2

    Topics: Animals; Bleeding Time; Blood Coagulation; Dermatan Sulfate; Disease Models, Animal; Fibrinolysis; Male; Rats; Rats, Wistar; Thrombophlebitis

1992
The effect of hyaluronic acid on cartilage in the immobilized rabbit knee.
    Acta orthopaedica Scandinavica, 1991, Volume: 62, Issue:4

    Topics: Animals; Arthritis; Cartilage, Articular; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Evaluation Studies as Topic; Hyaluronic Acid; Immobilization; Injections, Intra-Articular; Keratan Sulfate; Knee Joint; Rabbits; Uronic Acids

1991
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
    Thrombosis research, 1989, Jun-01, Volume: 54, Issue:5

    Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K

1989
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Annals of the New York Academy of Sciences, 1989, Volume: 556

    Topics: Animals; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Glycosaminoglycans; Heparin; Oligosaccharides; Partial Thromboplastin Time; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis

1989
Proteoglycans and hypertension: III: Aorta proteoglycans in Dahl salt-sensitive hypertensive rats.
    The American journal of the medical sciences, 1987, Volume: 293, Issue:3

    Topics: Animals; Aorta; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Hyaluronic Acid; Hypertension; Male; Proteoglycans; Rats; Sodium Chloride

1987
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties.
    Thrombosis research, 1988, Oct-15, Volume: 52, Issue:2

    Topics: Animals; Chondroitin; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Half-Life; Humans; Metabolic Clearance Rate; Partial Thromboplastin Time; Rabbits; Sulfuric Acids; Thrombosis

1988
Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I).
    Journal of neurochemistry, 1985, Volume: 45, Issue:4

    Topics: Animals; Brain Chemistry; Brain Stem; Dermatan Sulfate; Disease Models, Animal; Dog Diseases; Dogs; Electrophoresis, Cellulose Acetate; Female; Gangliosides; Glycosaminoglycans; Glycoside Hydrolases; Heparitin Sulfate; Iduronidase; Molecular Weight; Mucopolysaccharidoses; Sciatic Nerve

1985